| Affiliation: | 1. Wellcome-MRC Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Hills Road, Cambridge, CB2 0AW, United Kingdom;2. Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, United Kingdom;1. Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA;2. Molecular and Cellular Biology Program, Stony Brook University, Stony Brook, NY 11794, USA;1. Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, CA 91010, USA;2. Department of Clinical Science, Hematology Section, University of Bergen, Bergen 5021, Norway;3. KinN Therapeutics AS, Bergen 5008, Norway;4. Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen 5021, Norway;5. Department of Cancer Biology, City of Hope National Medical Center, Duarte, CA 91010, USA;6. Karolinska Institutet, Stockholm 17177, Sweden;7. Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway;1. Department of Medicine A, University of Muenster, 48149 Muenster, Germany;1. Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany;2. Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and DKFZ, 69120 Heidelberg, Germany;3. DKFZ-Heidelberg Center for Personalized Oncology (HIPO), 69120 Heidelberg, Germany;4. German Cancer Consortium (DKTK), 69120 Heidelberg, Germany |
